Русский
English
عربي
Future Pharma
Future Pharmaceutical Industries (FPI) is a leading Egyptian pharmaceutical company certified by cGMP standards. The company manufactures a wide range of pharmaceutical forms, including tablets, capsules, sachets, oral liquids, topicals, semisolids, creams, gels, and ointments. FPI covers nearly all therapeutic classes, such as:
- Cardiovascular diseases (CVS)
- Diabetes medications
- Gastrointestinal (GIT) treatments
- Central Nervous System (CNS) disorders
- Pain relief
- Antibiotics
- Respiratory diseases
- Rheumatic diseases
- Dermatology treatments
FPI is also a certified contract manufacturer for leading international and national pharmaceutical companies, thanks to its modern European-standard manufacturing equipment. (fpi-futurepharma.com)
Mission and Vision:
FPI aims to provide safe and effective medicines that contribute to improving the health and well-being of patients.
Product Portfolio:
Some of the products manufactured by FPI include:
- Coldatrexy Tab: A combination of paracetamol, dextromethorphan, phenylephrine, and chlorpheniramine for cold treatment.
- Jeparilon chewable Tab: A combination of famotidine, calcium carbonate, and magnesium hydroxide for heartburn and dyspepsia.
- Candalkan 16 mg FCT: A medication based on candesartan for the treatment of hypertension.
- Ibuprofen 400 mg: An anti-inflammatory medication used to treat pain and inflammation.
Manufacturing Facilities:
FPI operates modern manufacturing facilities that adhere to international standards, ensuring high-quality and efficient production.
Brand products
